|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 9/28 | |||
| A61K 9/48 | |||
| A61K 9/50 | |||
| A61K 31/40 | |||
| A61K 31/403 | |||
| A61K 31/60 | |||
| A61K 31/505 | |||
| A61K 31/616 | |||
| A61P 9/00 |
| (11) | Patento numeris | 2986281 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14728940.9 |
| Europos patento paraiškos padavimo data | 2014-06-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-12-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/061735 |
| Data | 2014-06-05 |
| (87) | Numeris | WO 2014/195421 |
| Data | 2014-12-11 |
| (30) | Numeris | Data | Šalis |
| 13170909 | 2013-06-06 | EP |
| (72) |
MARTIN SANZ, Pablo, ES
URBANO HURTADO, Javier, ES
|
| (73) |
Ferrer Internacional, S.A.,
Gran Via Carles III 94, 08028 Barcelona,
ES
Fundaci n Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Melchor Fernįndez Almagro, 3, 28029 Madrid, ES |
| (54) | ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |
| ORAL FORMULATION FOR THE TREATMENT OF CARDIOVASCULAR DISEASES |